GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSFF) » Definitions » Total Operating Expense

OSSFF (Embla Medical hf) Total Operating Expense : $422.6 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf Total Operating Expense?

Embla Medical hf's Total Operating Expense for the three months ended in Mar. 2025 was $105.9 Mil. Embla Medical hf's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $422.6 Mil.


Embla Medical hf Total Operating Expense Historical Data

The historical data trend for Embla Medical hf's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Total Operating Expense Chart

Embla Medical hf Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 337.97 359.76 372.61 398.11 421.95

Embla Medical hf Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.25 105.44 101.09 110.17 105.91

Embla Medical hf Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $422.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.

Embla Medical hf Headlines

From GuruFocus

Q1 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 10-09-2024

Ossur hf Corporate Analyst Meeting Transcript

By GuruFocus Research 02-14-2024

Preliminary Q2 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus Research 04-24-2024

Q3 2021 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 02-06-2025

Q3 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024